journal
Journals Journal of Enzyme Inhibition a...

Journal of Enzyme Inhibition and Medicinal Chemistry

https://read.qxmd.com/read/38078363/discovery-of-lah-1-as-potent-c-met-inhibitor-for-the-treatment-of-non-small-cell-lung-cancer
#41
JOURNAL ARTICLE
Lijie Sima, Zhongyuan Wang, Ling Yu, Youli Hou, Dongsheng Zhao, Bilan Luo, Weike Liao, Xinfu Liu
ABSTRCTDysregulated HGF/c-Met pathway has been implicated in multiple human cancers and has become an attractive target for cancer intervention. Herein, we report the discovery of N -(3-fluoro-4-((2-(3-hydroxyazetidine-1-carboxamido)pyridin-4-yl)oxy)phenyl)-1-(4-fluorophenyl)-4-methyl-6-oxo-1,6-dihydropyridazine-3-carboxamide ( LAH-1 ), which demonstrated nanomolar MET kinase activity as well as desirable antiproliferative activity, especially against EBC-1 cells. Mechanism studies confirmed the effects of LAH-1 on modulation of HGF/c-Met pathway, induction of cell apoptosis, inhibition on colony formation as well as cell migration and invasion...
December 2024: Journal of Enzyme Inhibition and Medicinal Chemistry
https://read.qxmd.com/read/38078360/9-10-dioxoanthracenyldithiocarbamates-effectively-inhibit-the-proliferation-of-non-small-cell-lung-cancer-by-targeting-multiple-protein-tyrosine-kinases
#42
JOURNAL ARTICLE
Mateusz Olszewski, Maryna Stasevych, Viktor Zvarych, Natalia Maciejewska
Anthraquinones have attracted considerable interest in the realm of cancer treatment owing to their potent anticancer properties. This study evaluates the potential of a series of new anthraquinone derivatives as anticancer agents for non-small-cell lung cancer (NSCLC). The compounds were subjected to a range of tests to assess their cytotoxic and apoptotic properties, ability to inhibit colony formation, pro-DNA damage functions, and capacity to inhibit the activity of tyrosine kinase proteins (PTKs). Based on the research findings, it has been discovered that most active derivatives ( i84 , i87 , and i90 ) possess a substantial capability to impede the viability of NSCLC while having mostly a negligible effect on the human kidney cell line...
December 2024: Journal of Enzyme Inhibition and Medicinal Chemistry
https://read.qxmd.com/read/38078358/design-synthesis-and-biological-evaluation-of-piperazine-derivatives-involved-in-the-5-ht-1a-r-bdnf-pka-pathway
#43
JOURNAL ARTICLE
Hao Zhou, Mengjiao Li, Hui Liu, Zheng Liu, Xuekun Wang, Shiben Wang
In this study, four series of piperazine derivatives were designed, synthesised and subjected to biological test, and compound 6a with potential antidepressant activity was obtained. An affinity assay of compound 6a with 5-hydroxytryptamine (serotonin, 5-HT)1A receptor (5-HT1A R) was undertaken, and the effects on the 5-HT level in the brains of mice were also tested. The results showed that compound 6a had the best affinity with 5-HT1A R ( K i = 1.28 nM) and significantly increased the 5-HT level. The expression levels of 5-HT1A R, BDNF, and PKA in the hippocampus were analysed by western blot and immunohistochemistry analyses...
December 2024: Journal of Enzyme Inhibition and Medicinal Chemistry
https://read.qxmd.com/read/38073431/synthesis-biological-evaluation-and-molecular-docking-of-isatin-hybrids-as-anti-cancer-and-anti-microbial-agents
#44
JOURNAL ARTICLE
Mohammad Altamimi, Saeed Ali Syed, Burak Tuzun, Mohammad Rashid Alhazani, Osamah Alnemer, Ahmed Bari
Isatin, known as 1 H -indole-2,3-dione, was originally recognised as a synthetic molecule until its discovery in the fruits of the cannonball tree, Couroupita guianensis . It is naturally occurring in plants of the genus Isatis and serves as a metabolic derivative of adrenaline in humans. Isatin possesses significant pharmacological importance, and its synthetic versatility has prompted extensive interest in its derivative compounds due to their diverse biological and pharmacological properties. These derivatives represent a valuable class of heterocyclic compounds with potential applications as precursors for synthesizing numerous valuable drugs...
December 2024: Journal of Enzyme Inhibition and Medicinal Chemistry
https://read.qxmd.com/read/38062554/design-and-synthesis-of-doublecortin-like-kinase-1-inhibitors-and-their-bioactivity-evaluation
#45
JOURNAL ARTICLE
Pengming Pan, Dengbo Ji, Zhongjun Li, Xiangbao Meng
Doublecortin-like kinase 1 (DCLK) is a microtubule-associated serine/threonine kinase that is upregulated in a wide range of cancers and is believed to be related to tumour growth and development. Upregulated DCLK1 has been used to identify patients at high risk of cancer progression and tumours with chemotherapy-resistance. Moreover, DCLK1 has been identified as a cancer stem cell (CSC) biomarker in various cancers, which has received considerable attention recently. Herein, a series of DCLK1 inhibitors were prepared based on the previously reported XMD8-92 structure...
December 2024: Journal of Enzyme Inhibition and Medicinal Chemistry
https://read.qxmd.com/read/38062550/novel-tetrahydronaphthalen-1-yl-phenethyl-ureas-synthesis-and-dual-antibacterial-anticancer-activities
#46
JOURNAL ARTICLE
Yusuf Akbaba, Fatma Necmiye Kacı, Mehmet Enes Arslan, Süleyman Göksü, Adil Mardinoğlu, Hasan Türkez
Cancer and antibiotic-resistant bacterial infections are significant global health challenges. The resistance developed in cancer treatments intensifies therapeutic difficulties. In addressing these challenges, this study synthesised a series of N,N'-dialkyl urea derivatives containing methoxy substituents on phenethylamines. Using isocyanate for the efficient synthesis yielded target products 14-18 in 73-76% returns. Subsequently, their antibacterial and anticancer potentials were assessed. Cytotoxicity tests on cancer cell lines, bacterial strains, and a healthy fibroblast line revealed promising outcomes...
December 2024: Journal of Enzyme Inhibition and Medicinal Chemistry
https://read.qxmd.com/read/38059334/searching-for-novel-mdm2-mdmx-dual-inhibitors-through-a-drug-repurposing-approach
#47
JOURNAL ARTICLE
Keting Li, Wenshu Hu, Yingjie Wang, Wenxing Chen, Hongmei Wen, Jian Liu, Wei Li, Bo Wang
Disruption of p53-MDM2/MDMX interaction by smaller inhibitors is a promising therapeutic intervention gaining tremendous interest. However, no MDM2/MDMX inhibitors have been marketed so far. Drug repurposing is a validated, practical approach to drug discovery. In this regard, we employed structure-based virtual screening in a reservoir of marketed drugs and identified nintedanib as a new MDM2/MDMX dual inhibitor. The computational structure analysis and biochemical experiments uncover that nintedanib binds MDM2/MDMX similarly to RO2443, a dual MDM2/MDMX inhibitor...
December 2024: Journal of Enzyme Inhibition and Medicinal Chemistry
https://read.qxmd.com/read/38059332/novel-dual-targeting-inhibitors-of-nsd2-and-hdac2-for-the-treatment-of-liver-cancer-structure-based-virtual-screening-molecular-dynamics-simulation-and-in%C3%A2-vitro-and-in%C3%A2-vivo-biological-activity-evaluations
#48
JOURNAL ARTICLE
Xing Jin, Yuting Wang, Jing Chen, Miaomiao Niu, Yang Yang, Qiaoxuan Zhang, Guangyu Bao
Liver cancer exhibits a high degree of heterogeneity and involves intricate mechanisms. Recent research has revealed the significant role of histone lysine methylation and acetylation in the epigenetic regulation of liver cancer development. In this study, five inhibitors capable of targeting both histone lysine methyltransferase nuclear receptor-binding SET domain 2 (NSD2) and histone deacetylase 2 (HDAC2) were identified using a structure-based virtual screening approach. Notably, DT-NH-1 displayed a potent inhibition of NSD2 (IC50 = 0...
December 2024: Journal of Enzyme Inhibition and Medicinal Chemistry
https://read.qxmd.com/read/38059302/identification-of-putative-allosteric-inhibitors-of-bckdk-via-virtual-screening-and-biological-evaluation
#49
JOURNAL ARTICLE
Chunqiong Li, Quanjun Yang, Li Zhang
Abnormal accumulation of branched-chain amino acids (BCAAs) can lead to metabolic diseases and cancers. Branched-chain α-keto acid dehydrogenase kinase (BCKDK) is a key negative regulator of BCAA catabolism, and targeting BCKDK provides a promising therapeutic approach for diseases caused by BCAA accumulation. Here, we screened PPHN and POAB as novel putative allosteric inhibitors by integrating allosteric binding site prediction, large-scale ligand database virtual screening, and bioactivity evaluation assays...
December 2024: Journal of Enzyme Inhibition and Medicinal Chemistry
https://read.qxmd.com/read/38059272/evaluation-of-n-alkyl-isatins-and-indoles-as-acetylcholinesterase-and-butyrylcholinesterase-inhibitors
#50
JOURNAL ARTICLE
Kaitlyn N Alcorn, Isabelle A Oberhauser, Matthew D Politeski, Todd J Eckroat
Two series of N -alkyl isatins and N -alkyl indoles varying in size of the alkyl group were synthesised and evaluated for inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE). Among the N -alkyl isatins 4a - j , the addition of the N -alkyl group improved inhibition potency towards AChE and BChE compared to isatin. Selectivity towards inhibition of BChE was observed, and the increase in size of the N -alkyl group positively correlated to improved inhibition potency. The most potent inhibitor for BChE was 4i (IC50 = 3...
December 2024: Journal of Enzyme Inhibition and Medicinal Chemistry
https://read.qxmd.com/read/38058285/suppression-of-lipopolysaccharide-induced-cox-2-expression-via-p38mapk-jnk-and-c-ebp%C3%AE-phosphorylation-inhibition-by-furomagydarin-a-a-benzofuran-glycoside-from-magydaris-pastinacea
#51
JOURNAL ARTICLE
Shiu-Wen Huang, Ming Jen Hsu, Hsiu-Chen Chen, Rita Meleddu, Simona Distinto, Elias Maccioni, Filippo Cottiglia
The phytochemical investigation of the methanol extract of the seeds of Magydaris pastinacea afforded two undescribed benzofuran glycosides, furomagydarins A-B ( 1 , 2 ), together with three known coumarins. The structures of the new isolates were elucidated after extensive 1D and 2D NMR experiments as well as HR MS. Compound 1 was able to inhibit the COX-2 expression in RAW264.7 macrophages exposed to lipopolysaccharide, a pro-inflammatory stimulus. RT-qPCR and luciferase reporter assays suggested that compound 1 reduces COX-2 expression at the transcriptional level...
December 2024: Journal of Enzyme Inhibition and Medicinal Chemistry
https://read.qxmd.com/read/38061987/a-method-for-the-efficient-evaluation-of-substrate-based-cholinesterase-imaging-probes-for-alzheimer-s-disease
#52
JOURNAL ARTICLE
Sultan Darvesh, Scott Banfield, Maeve Dufour, Katrina L Forrestall, Hillary Maillet, G Andrew Reid, Dane Sands, Ian R Pottie
Cholinesterase (ChE) enzymes have been identified as diagnostic markers for Alzheimer disease (AD). Substrate-based probes have been synthesised to detect ChEs but they have not detected changes in ChE distribution associated with AD pathology. Probes are typically screened using spectrophotometric methods with pure enzyme for specificity and kinetics. However, the biochemical properties of ChEs associated with AD pathology are altered. The present work was undertaken to determine whether the Karnovsky-Roots (KR) histochemical method could be used to evaluate probes at the site of pathology...
December 2023: Journal of Enzyme Inhibition and Medicinal Chemistry
https://read.qxmd.com/read/38061801/new-1-2-3-triazole-1-2-4-triazole-hybrids-linked-to-oxime-moiety-as-nitric-oxide-donor-selective-cox-2-aromatase-b-raf-v600e-and-egfr-inhibitors-celecoxib-analogs-design-synthesis-anti-inflammatory-anti-proliferative-activities-apoptosis-and-molecular-modeling
#53
JOURNAL ARTICLE
Wael A A Fadaly, Mohamed T M Nemr, Taha H Zidan, Fatma E A Mohamed, Marwa M Abdelhakeem, Nour N Abu Jayab, Hany A Omar, Khaled R A Abdellatif
A new series of bis-triazole 19a-l was synthesised for the purpose of being hybrid molecules with both anti-inflammatory and anti-cancer activities and assessed for cell cycle arrest, NO release. Compounds 19c , 19f , 19h , 19 l exhibited COX-2 selectivity indexes in the range of 18.48 to 49.38 compared to celecoxib S.I. = 21.10), inhibit MCF-7 with IC50 = 9-16 μM compared to tamoxifen (IC50 = 27.9 μM). and showed good inhibitory activity against HEP-3B with IC50 = 4.5-14 μM compared to sorafenib (IC50 = 3...
December 2023: Journal of Enzyme Inhibition and Medicinal Chemistry
https://read.qxmd.com/read/38010912/new-pyrazolyl-thiazolidinone-thiazole-derivatives-as-celecoxib-dasatinib-analogues-with-selective-cox-2-her-2-and-egfr-inhibitory-effects-design-synthesis-anti-inflammatory-anti-proliferative-activities-apoptosis-molecular-modelling-and-adme-studies
#54
JOURNAL ARTICLE
Wael A A Fadaly, Taha H Zidan, Nesma M Kahk, Fatma E A Mohamed, Marwa M Abdelhakeem, Rehab G Khalil, Mohamed T M Nemr
Two new series of pyrazolyl-thiazolidinone/thiazole derivatives 16a-b and 18a-j were synthesised, merging the scaffolds of celecoxib and dasatinib. Compounds 16a , 16b and 18f inhibit COX-2 with S.I. 134.6, 26.08 and 42.13 respectively (celecoxib S.I. = 24.09). Compounds 16a, 16b, 18c, 18d and 18f inhibit MCF-7 with IC50 = 0.73-6.25 μM (dasatinib IC50 = 7.99 μM) and (doxorubicin IC50 = 3.1 μM) and inhibit A549 with IC50 = 1.64-14.3 μM (dasatinib IC50 = 11...
December 2023: Journal of Enzyme Inhibition and Medicinal Chemistry
https://read.qxmd.com/read/37994663/new-spiro-indeno-1-2-b-quinoxalines-clubbed-with-benzimidazole-scaffold-as-cdk2-inhibitors-for-halting-non-small-cell-lung-cancer-stereoselective-synthesis-molecular-dynamics-and-structural-insights
#55
JOURNAL ARTICLE
Assem Barakat, Saeed Alshahrani, Abdullah Mohammed Al-Majid, Abdullah Saleh Alamary, Matti Haukka, Marwa M Abu-Serie, Luis R Domingo, Sajda Ashraf, Zaheer Ul-Haq, Mohamed S Nafie, Mohamed Teleb
Despite the crucial role of CDK2 in tumorigenesis, few inhibitors reached clinical trials for managing lung cancer, the leading cause of cancer death. Herein, we report combinatorial stereoselective synthesis of rationally designed spiroindeno[1,2- b ]quinoxaline-based CDK2 inhibitors for NSCLC therapy. The design relied on merging pharmacophoric motifs and biomimetic scaffold hopping into this privileged skeleton via cost-effective one-pot multicomponent [3 + 2] cycloaddition reaction. Absolute configuration was assigned by single crystal x-ray diffraction analysis and reaction mechanism was studied by Molecular Electron Density Theory...
December 2023: Journal of Enzyme Inhibition and Medicinal Chemistry
https://read.qxmd.com/read/37994421/inhibition-of-pathogenic-bacterial-carbonic-anhydrases-by-monothiocarbamates
#56
JOURNAL ARTICLE
Simone Giovannuzzi, Anil Kumar Marapaka, Nader S Abutaleb, Fabrizio Carta, Hsin-Wen Liang, Alessio Nocentini, Luigi Pisano, Mohamed N Seleem, Daniel P Flaherty, Claudiu T Supuran
Carbonic anhydrases (CAs) from the pathogenic bacteria Nesseria gonorrhoeae and vancomycin-resistant enterococci (VRE) have recently been validated as antibacterial drug targets. Here we explored the inhibition of the α-CA from N. gonorrhoeae (α-NgCA), of α- and γ-class enzymes from Enterococcus faecium (α-EfCA and γ-EfCA) with a panel of aliphatic, heterocyclic and aryl-alkyl primary/secondary monothiocarbamates (MTCs). α-NgCA was inhibited in vitro with KI s ranging from 0...
December 2023: Journal of Enzyme Inhibition and Medicinal Chemistry
https://read.qxmd.com/read/37985663/the-multifaceted-nature-of-plant-acid-phosphatases-purification-biochemical-features-and-applications
#57
REVIEW
Lokesh Sharma, Amol Kahandal, Anant Kanagare, Atul Kulkarni, Chandrakant K Tagad
Acid phosphatases (EC 3.1.3.2) are the enzymes that catalyse transphosphorylation reactions and promotes the hydrolysis of numerous orthophosphate esters in acidic media, as a crucial element for the metabolism of phosphate in tissues. Inorganic phosphate (Pi) utilisation and scavenging, as well as the turnover of Pi-rich sources found in plant vacuoles, are major processes in which intracellular and secretory acid phosphatases function. Therefore, a thorough understanding of these enzymes' structural characteristics, specificity, and physiochemical properties is required to comprehend the function of acid phosphatases in plant energy metabolism...
December 2023: Journal of Enzyme Inhibition and Medicinal Chemistry
https://read.qxmd.com/read/37985494/synthesis-biological-evaluation-and-computational-studies-of-n-benzyl-pyridinium-curcumin-derivatives-as-potent-ache-inhibitors-with-antioxidant-activity
#58
JOURNAL ARTICLE
Nafisah M Al-Rifai, Nemeh M Al-Khalileh, Jalal A Zahra, Musa I El-Barghouthi, Fouad H Darras
A library of N -benzylpyridinium-based compounds, 7a-j and 8a-j , was designed and synthesised as potential acetylcholinesterase) AChE (inhibitors. An in vitro assay for the synthesised compounds showed that most compounds had significant AChE inhibitory activities at the nanomolar and submicromolar levels. The benzyl ( 8a ) and fluoro ( 8b ) derivatives were the most active, with IC50 values ≤56 nM. Compound 7f, which had a benzyl moiety, showed the highest potency among all the target compounds, with an IC50 value of 7...
December 2023: Journal of Enzyme Inhibition and Medicinal Chemistry
https://read.qxmd.com/read/37982203/novel-n-arylmethyl-aniline-chalcone-hybrids-as-potential-vegfr-inhibitors-synthesis-biological-evaluations-and-molecular-dynamic-simulations
#59
JOURNAL ARTICLE
Hesham Haffez, Nosaiba A Elsayed, Marwa F Ahmed, Samar S Fatahala, Eman F Khaleel, Rehab Mustafa Badi, Eslam B Elkaeed, Mahmoud A El Hassab, Sherif F Hammad, Wagdy M Eldehna, Nicolas Masurier, Radwan El-Haggar
Significant advancements have been made in the domain of targeted anticancer therapy for the management of malignancies in recent times. VEGFR-2 is characterised by its pivotal involvement in angiogenesis and subsequent mechanisms that promote tumour cells survival. Herein, novel N -arylmethyl-aniline/chalcone hybrids 5a-5n were designed and synthesised as potential anticancer and VEGFR-2 inhibitors. The anticancer activity was evaluated at the NCI-USA, resulting in the identification of 10 remarkably potent molecules 5a-5j that were further subjected to the five-dose assays...
December 2023: Journal of Enzyme Inhibition and Medicinal Chemistry
https://read.qxmd.com/read/37975328/methotrexate-an-anti-inflammatory-drug-inhibits-hepatitis-e-viral-replication
#60
JOURNAL ARTICLE
Akash Kumar, Preeti Hooda, Anindita Puri, Radhika Khatter, Mohammed S Al-Dosari, Neha Sinha, Mohammad K Parvez, Deepak Sehgal
Hepatitis E Virus (HEV) is a positively oriented RNA virus having a 7.2 kb genome. HEV consists of three open reading frames (ORF1-3). Of these, ORF1 codes for the enzymes Methyltransferase (Mtase), Papain-like cysteine protease (PCP), RNA helicase, and RNA-dependent RNA polymerase (RdRp). Unavailability of a vaccine or effective drug against HEV and considering the side effects associated with the off-label use of ribavirin (RBV) and pegylated interferons, an alternative approach is required by the modulation of specific enzymes to prevent the infection...
December 2023: Journal of Enzyme Inhibition and Medicinal Chemistry
journal
journal
40233
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.